
AstraZeneca PLC AZN
Annual report 2024
added 01-24-2026
AstraZeneca PLC EBITDA per Share 2011-2026 | AZN
Annual EBITDA per Share AstraZeneca PLC
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 0.74 | 1.98 | 1.12 | 1.34 | 1.45 | 1.45 | 1.28 | 0.918 | 1.53 | 3.27 | 4.81 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.81 | 0.74 | 1.81 |
Quarterly EBITDA per Share AstraZeneca PLC
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 0.86 | - | - | - | 0.98 | - | - | - | 0.38 | - | - | - | 0.6 | - | - | - | 0.73 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.98 | 0.38 | 0.71 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-0.97 | $ 18.36 | -0.78 % | $ 2.7 B | ||
|
Amgen
AMGN
|
23.9 | $ 343.69 | 0.53 % | $ 185 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
0.9 | $ 70.78 | 2.09 % | $ 9.47 B | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Aytu BioScience
AYTU
|
-0.39 | $ 2.66 | 2.31 % | $ 16.7 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
-0.63 | $ 2.97 | 8.0 % | $ 167 M | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.14 | -0.95 % | $ 7.55 B | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Aptose Biosciences
APTO
|
0.05 | - | -45.71 % | $ 1.2 M | ||
|
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | ||
|
Biogen
BIIB
|
4.62 | $ 179.14 | -0.42 % | $ 26.1 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-0.24 | $ 1.41 | -0.35 % | $ 264 M | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | ||
|
Ascendis Pharma A/S
ASND
|
-8.25 | $ 223.85 | -1.0 % | $ 5 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 9.82 | 1.34 % | $ 1.59 B | ||
|
BioNTech SE
BNTX
|
62.6 | $ 110.32 | -3.02 % | $ 27.2 B | ||
|
Athira Pharma
ATHA
|
-2.6 | - | - | $ 269 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
Autolus Therapeutics plc
AUTL
|
-0.92 | $ 1.39 | 1.09 % | $ 355 M | ||
|
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
Cardiff Oncology
CRDF
|
-1.01 | $ 1.72 | -1.71 % | $ 82 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.01 | $ 4.13 | 2.99 % | $ 8.99 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-0.11 | - | -15.15 % | $ 60.3 M | ||
|
Brickell Biotech
BBI
|
-1.17 | - | -5.38 % | $ 6.06 M | ||
|
Amneal Pharmaceuticals
AMRX
|
1.01 | $ 14.13 | 3.25 % | $ 4.37 B | ||
|
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | ||
|
Atreca
BCEL
|
0.14 | - | -11.76 % | $ 5.79 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
-0.01 | $ 6.69 | 1.6 % | $ 1.38 B | ||
|
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | ||
|
Beam Therapeutics
BEAM
|
-4.78 | $ 27.78 | 0.58 % | $ 2.29 B | ||
|
BeiGene, Ltd.
BGNE
|
-0.29 | - | 0.49 % | $ 251 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M |